Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert P Frantz

Showing results (31-40 of 194) with videos related to

Pageof 20
Sort By:
Pulmonary Circulation|January 13, 2022
Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertensionKellie Morland, Amresh Raina, Abigail Nails, et al.
Mayo Clinic Proceedings|October 9, 2003
Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapySundeep Bhatia, Robert P Frantz, Cathy J Severson, et al.
American Journal of Respiratory and Critical Care Medicine|October 24, 2025
A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary HypertensionAkshay Kohli, Hilary M DuBrock, Jennifer M Boland, et al.
American Journal of Respiratory and Critical Care Medicine|June 10, 2026
Reply to Montani et al.: Venular remodeling as an Integral Component of CTEPH Rather Than a Distinct PathologyAkshay Kohli, Hilary M Dubrock, Jennifer M Boland, et al.
Circulation. Cardiovascular Interventions|December 21, 2021
Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial HypertensionJason H Anderson, Allison K Cabalka, Robert P Frantz, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Portopulmonary hypertension: Results from a 10-year screening algorithmMichael J Krowka, Karen L Swanson, Robert P Frantz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 31, 2011
The usefulness of submaximal exercise gas exchange to define pulmonary arterial hypertensionPaul R Woods, Robert P Frantz, Bryan J Taylor, et al.
American Heart Journal|February 20, 2007
Repeat length polymorphism of the serotonin transporter gene influences pulmonary artery pressure in heart failureThomas P Olson, Eric M Snyder, Robert P Frantz, et al.
Journal of Cardiac Failure|May 13, 2014
Hemodynamic ranges during daily activities and exercise testing in patients with pulmonary arterial hypertensionBarbro Kjellström, Robert P Frantz, Raymond L Benza, et al.
Transplantation|April 15, 2008
Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patientsEugenia Raichlin, Joseph P McConnell, Jang-Ho Bae, et al.
Pageof 20

Showing results (31-40 of 194) with videos related to

Sort By:
Pageof 20
Pulmonary Circulation|January 13, 2022
Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertensionKellie Morland, Amresh Raina, Abigail Nails, et al.
Mayo Clinic Proceedings|October 9, 2003
Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapySundeep Bhatia, Robert P Frantz, Cathy J Severson, et al.
American Journal of Respiratory and Critical Care Medicine|October 24, 2025
A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary HypertensionAkshay Kohli, Hilary M DuBrock, Jennifer M Boland, et al.
American Journal of Respiratory and Critical Care Medicine|June 10, 2026
Reply to Montani et al.: Venular remodeling as an Integral Component of CTEPH Rather Than a Distinct PathologyAkshay Kohli, Hilary M Dubrock, Jennifer M Boland, et al.
Circulation. Cardiovascular Interventions|December 21, 2021
Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial HypertensionJason H Anderson, Allison K Cabalka, Robert P Frantz, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Portopulmonary hypertension: Results from a 10-year screening algorithmMichael J Krowka, Karen L Swanson, Robert P Frantz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 31, 2011
The usefulness of submaximal exercise gas exchange to define pulmonary arterial hypertensionPaul R Woods, Robert P Frantz, Bryan J Taylor, et al.
American Heart Journal|February 20, 2007
Repeat length polymorphism of the serotonin transporter gene influences pulmonary artery pressure in heart failureThomas P Olson, Eric M Snyder, Robert P Frantz, et al.
Journal of Cardiac Failure|May 13, 2014
Hemodynamic ranges during daily activities and exercise testing in patients with pulmonary arterial hypertensionBarbro Kjellström, Robert P Frantz, Raymond L Benza, et al.
Transplantation|April 15, 2008
Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patientsEugenia Raichlin, Joseph P McConnell, Jang-Ho Bae, et al.
Pageof 20